Hesitancy of Influenza Vaccination in Thai Patients with Type 2 Diabetes Mellitus: A Cross-sectional Study in Burapha University Hospital, Chonburi, Thailand
Keywords:
Influenza vaccination, Type 2 Diabetes Mellitus, Vaccine hesitancyAbstract
Objective: Despite influenza vaccines being recommended to patients with type 2 diabetes (T2DM), the coverage was still low. This study measured influenza vaccine hesitancy and identify associated factors among T2DM patients at the Burapha University Hospital.
Methods: This cross-sectional study was conducted during May-August 2020. Participants were recruited from T2DM patients visited the hospital for continuity care. The research gathered demographic data; medical data were retrieved from electronic medical records. Statistical analysis was performed for those who received the influenza vaccine compared to those who decided not to receive the vaccine.
Results: A total of 304 T2DM patients (female 54%, mean age 63 years, BMI 26.49kg/m2, HbA1c 7.63%) were included into the study. One-third (30.6%) never had the vaccine. The hesitancy rate was 38%. When adjusted for demographic and medical data, T2DM patients aged< 65 years and never had influenza vaccines were significantly associated with the hesitancy.The top reason overall was lack of knowledge and awareness. Many patients did not haveinfluenza vaccination because they had never received a vaccine recommendation from a primary provider.
Conclusions: Hesitancy to influenza vaccination was substantial among our T2DM patients especially those who were younger and never had the vaccine. Primary providers have a major role to raise the knowledge and awareness of influenza vaccine toward this vulnerable population.
This article has a correction.
Please see: Erratum for the Research Article “Hesitancy of Influenza Vaccination in Thai Patients with Type 2 Diabetes Mellitus: A Cross-sectional Study in Burapha University Hospital, Chonburi, Thailand” by Katkanit Thammakumpee and Vorapot Sapsirisavat 29 September 2022
Downloads
References
Li S, Wang J, Zhang B, Li X, Liu Y. Diabetes Mellitus and Cause-Specific Mortality: A Population-Based Study. Diabetes Metab J. 2019;43(3):319-341.
Cooper BS, Kotirum S, Kulpeng W, et al. Mortality attributable to seasonal influenza A and B infections in Thailand, 2005-2009: a longitudinal study. Am J Epidemiol. 2015;181(11):898-907.
World Health Organization. WHO SAGE Seasonal Influenza Vaccination Recommendations during the COVID-19 Pandemic - September 2020. World Health Organization; 2020.
Yang TU, Song JY, Noh JY, Cheong HJ, Kim WJ. Influenza and Pneumococcal Vaccine Coverage Rates among Patients Admitted to a Teaching Hospital in South Korea. Infect Chemother. 2015;47(1):41-48.
O'Halloran AC, Lu PJ, Williams WW, Bridges CB, Singleton JA. Influenza Vaccination Coverage Among People With High-Risk Conditions in the U.S. Am J Prev Med. 2016;50(1):15-26.
Yu MC, Chou YL, Lee PL, Yang YC, Chen KT. Influenza vaccination coverage and factors affecting adherence to influenza vaccination among patients with diabetes in Taiwan. Hum Vaccin Immunother. 2014;10(4):1028-1035.
World Health Organization. Weekly epidemiological record No.33.World Health Organization; 2005.
Owusu JT, Prapasiri P, Ditsungnoen D, et al. Seasonal influenza vaccine coverage among high-risk populations in Thailand, 2010-2012. Vaccine. 2015;33(5):742-747.
NHSO.National Health Security Office. http://www.healtharea.netwp-content. Published 2016. Accessed October 7, 2020.
Thewjitcharoen Y, Butadej S, Malidaeng A, et al. Trends in influenza and pneumococcal vaccine coverage in Thai patients with type 2 diabetes mellitus 2010-2018: Experience from a tertiary diabetes center in Bangkok. J Clin Transl Endocrinol. 2020;20:100227.
Chanapol C, Srisompoch S, Sittichockchai P, Thanapruksanan P. Factors associated with influenza vaccine acceptance among Diabetes patients in tambon Tapan health promoting hospital, Phatthalung province, Phatthalung academic fair 2019, 18 - 19 June 2019. http://data.ptho.moph.go.th/ptvichakarn62/uploads/86444_0201_20190607202736.pdf. Accessed October 7, 2020.
Siriphakhamongkhon A. Socio-Demographic and Health Factors Influencing on Preventive Behavior of Influenza Virus in Patients with Diabetes in Nakhon Sawan Province. JDPC3. 2019;12(2):26-40.
MacDonald NE. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33(34):4161-4164.
Hulme KD, Gallo LA, Short KR. Influenza Virus and Glycemic Variability in Diabetes: A Killer Combination?. Front Microbiol. 2017;8:861.
Jiménez-Garcia R, Lopez-de-Andres A, Hernandez-Barrera V, et al. Influenza vaccination in people with type 2 diabetes, coverage, predictors of uptake, and perceptions. Result of the MADIABETES cohort a 7 years follow up study. Vaccine. 2017;35(1):101-108.
Lane S, MacDonald NE, Marti M, Dumolard L. Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015-2017. Vaccine. 2018;36(26):3861-3867.
Worasathit R, Wattana W, Okanurak K, Songthap A, Dhitavat J, Pitisuttithum P. Health education and factors influencing acceptance of and willingness to pay for influenza vaccination among older adults. BMC Geriatr. 2015;15:136.
Phrommintikul A, Wongcharoen W, Kuanprasert S, et al. Safety and tolerability of intradermal influenza vaccination in patients with cardiovascular disease. J Geriatr Cardiol. 2014;11(2):131-135.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
